| Characteristic | No. of patients | Percentage |
| No. of patients enrolled Assessable for response Lost to follow-up | 40 35 05 | 100 87.5 12.5 |
| Age (Years) Median (48) Range (24 - 67) | ||
| Sex Male Female | 10 30 | 25 75 |
| Performance status (ECOG scale) 0 1 2 | 24 06 10 | 60 15 25 |
| Extent of disease Locally advanced Metastatic Recurrent | 04 30 10 | 10 75 25 |
| Metastatic Sites Liver Abd. Lymph nodes Lung Supraclavicular lymph nodes Peritoneum Bone | 16 10 05 03 08 02 | 40 25 12.5 07.5 20 5 |